ZEVRA THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Zevra Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2015 to Q2 2024.
  • Zevra Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 41.9M shares, a 23.6% increase year-over-year.
  • Zevra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 35.5M shares, a 2.79% increase from 2022.
  • Zevra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 34.5M shares, a 15.9% increase from 2021.
  • Zevra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 29.8M shares, a 648% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 41.9M +8M +23.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 41.8M +7.31M +21.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 35.5M +964K +2.79% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 34.7M +230K +0.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 33.9M -549K -1.59% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 34.5M -40.1K -0.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 34.5M +4.72M +15.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 34.5M -723K -2.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 34.4M +5.27M +18.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 34.5M +15.4M +80.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 29.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 35.2M +30.8M +696% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 29.2M +25.2M +639% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 19.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 4.43M -25.7M -85.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 3.95M -24.4M -86.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q3 2019 30.1M +14.1M +87.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 28.4M +13.1M +85.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q3 2018 16M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 15.3M +668K +4.56% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q2 2017 14.6M +52.1K +0.36% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q2 2016 14.6M +2.44M +20.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q2 2015 12.2M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.